{
    "organizations": [],
    "uuid": "976cbcd8ead49ef99901d037c1eee656513d53a9",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-oncopeptides-additional-patent-pro/brief-oncopeptides-additional-patent-protection-for-ygalo-in-japan-idUSFWN1QQ06J",
    "ord_in_thread": 0,
    "title": "BRIEF-Oncopeptides Additional Patent Protection For Ygalo In Japan",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 8 (Reuters) - Oncopeptides Ab:\n* ADDITIONAL PATENT PROTECTION FOR YGALOÂ® HAS BEEN GRANTED IN JAPAN UNTIL 2033 Source text for Eikon: Further company coverage: (Gdynia Newsroom)\nOur Standards: The Thomson Reuters Trust Principles.",
    "published": "2018-03-08T15:06:00.000+02:00",
    "crawled": "2018-03-09T14:14:33.012+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "oncopeptides",
        "ab",
        "additional",
        "patent",
        "protection",
        "granted",
        "japan",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom",
        "standard",
        "thomson",
        "reuters",
        "trust",
        "principle"
    ]
}